Stay updated on REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page.

Latest updates to the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed study objectives and inclusion/exclusion criteria for a clinical trial on Atopic Dermatitis, while retaining the study's collaborators and revision number.SummaryDifference9%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.6%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.6%
Stay in the know with updates to REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page.